can tirzepatide cause vision changes Semaglutide, Linked to Small Increase in Eye Disorder Risk glp 1 blindness study Do

The injection has been approved by the FDA to manage Type II diabetes and chronic weight management in adults with obesity and is administered once weekly (1-5)

What to monitor while taking Mounjaro If you have fatty liver disease and are taking Mounjaro, your healthcare provider may recommend: Liver function blood tests: Periodic checks of liver enzymes (ALT, AST) can help track your livers response to treatment

Dietary considerations become particularly relevant during the initial titration phase when gastrointestinal side effects such as nausea, vomiting, and abdominal discomfort are most common

People with specific genetic predispositionsparticularly in sulfur metabolism pathways or homocysteine regulationmay require provider monitoring to ensure supplementation supports rather than strains metabolic balance

Semaglutide versus retatrutide Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors